Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Use this AUPH page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AUPH quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AUPH SEC filings page. Lician reads the product cache first so this HTML stays unique to Aurinia Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full AUPH income, balance, and cash tables.